Great Lakes Advisors LLC Takes $702,000 Position in Agilon Health, Inc. $AGL

Great Lakes Advisors LLC acquired a new position in Agilon Health, Inc. (NYSE:AGL) in the second quarter, Holdings Channel.com reports. The fund acquired 6,549 shares of the company’s stock, valued at approximately $702,000.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the business. LPL Financial LLC raised its stake in Agilon Health by 213.4% in the fourth quarter. LPL Financial LLC now owns 44,055 shares of the company’s stock valued at $30,000 after buying an additional 30,000 shares during the last quarter. CIBC Bancorp USA Inc. acquired a new stake in Agilon Health in the third quarter worth about $34,000. Krilogy Financial LLC purchased a new stake in shares of Agilon Health during the fourth quarter worth about $34,000. Merit Financial Group LLC purchased a new stake in shares of Agilon Health during the fourth quarter worth about $35,000. Finally, Focus Partners Advisor Solutions LLC purchased a new stake in shares of Agilon Health during the fourth quarter worth about $53,000.

Agilon Health Stock Performance

Shares of AGL opened at $96.32 on Friday. The company has a debt-to-equity ratio of 0.07, a quick ratio of 1.08 and a current ratio of 1.08. The stock has a 50-day moving average of $105.84 and a two-hundred day moving average of $60.88. The stock has a market cap of $1.62 billion, a P/E ratio of -6.75 and a beta of 3.01. Agilon Health, Inc. has a one year low of $7.48 and a one year high of $133.04.

Agilon Health (NYSE:AGL) last announced its quarterly earnings data on Wednesday, August 5th. The company reported $1.04 earnings per share for the quarter, beating analysts’ consensus estimates of $0.14 by $0.90. The business had revenue of $1.49 billion for the quarter, compared to analyst estimates of $1.45 billion. Agilon Health had a negative return on equity of 119.38% and a negative net margin of 3.92%. As a group, research analysts predict that Agilon Health, Inc. will post -2.95 EPS for the current year.

Analyst Upgrades and Downgrades

Several equities analysts recently commented on AGL shares. Wall Street Zen raised shares of Agilon Health from a “sell” rating to a “hold” rating in a research report on Saturday, May 9th. Truist Financial set a $112.00 target price on shares of Agilon Health and gave the stock a “hold” rating in a research report on Thursday, August 6th. JPMorgan Chase & Co. downgraded shares of Agilon Health from a “neutral” rating to an “underweight” rating and set a $21.00 target price on the stock. in a research report on Monday, May 4th. Benchmark restated a “buy” rating and set a $140.00 price target (up from $95.00) on shares of Agilon Health in a research note on Thursday, August 6th. Finally, Robert W. Baird set a $116.00 price target on shares of Agilon Health in a report on Thursday, August 6th. Five equities research analysts have rated the stock with a Buy rating, seven have given a Hold rating and two have given a Sell rating to the stock. According to MarketBeat, Agilon Health has a consensus rating of “Hold” and an average target price of $91.30.

About Agilon Health

Agilon Health (NYSE: AGL) is a healthcare company that partners with independent primary care physicians to deliver value-based care for Medicare beneficiaries. Through risk-sharing arrangements, Agilon assumes financial responsibility for patient populations, enabling physicians to focus on preventive and proactive health management. The company provides the administrative, clinical and operational infrastructure needed to support comprehensive care delivery.

Agilon’s platform encompasses data analytics, care management, patient engagement tools and population health programs.